EO

Ethan Oren Perlstein

North America, California, United States, San Francisco

Description

Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with P...

Investor Profile

Ethan Oren Perlstein has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • Canada (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Cannabis
  • Cosmetics
  • Life Science
  • Nutraceutical
  • Personal Health
  • Pharmaceutical
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ethan Oren Perlstein frequently co-invest with?

SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 1
Pioneer Fund
North America, California, United States, San Francisco
Co-Investments: 1
Asymmetry Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Founders, Inc.
North America, California, United States, San Francisco
Co-Investments: 1
RebelBio
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Ethan Oren Perlstein often collaborate with?

AH
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Ethan Oren Perlstein?

Promakhos Therapeutics

Boston, Massachusetts, United States

Promakhos Therapeutics provides a therapeutics platform for curing inflammatory disorders.

BiotechnologyHealth CareTherapeutics
SeedSep 2, 2021
Hyasynth Bio

Montréal, Quebec, Canada

We make Better Cannabinoids through sustainable biotechnology.

BiopharmaBiotechnologyCannabisCosmeticsLife ScienceNutraceuticalPersonal HealthPharmaceutical
SeedJun 29, 2015